184 related articles for article (PubMed ID: 16491555)
1. [Why patent-protected drugs' cost efficiency should be compared with generic preparations].
Berggren F; Lundin D; Ramsberg J
Lakartidningen; 2006 Jan 25-31; 103(4):223-4. PubMed ID: 16491555
[No Abstract] [Full Text] [Related]
2. Drug costs threaten patent protection.
Cimons M
Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
[No Abstract] [Full Text] [Related]
3. Lowering the cost of prescription drugs.
Jindal B
J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276
[No Abstract] [Full Text] [Related]
4. [Discount for only one drug of the same group leads to impaired health care quality].
Bergström R
Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
[No Abstract] [Full Text] [Related]
5. Statin utilisation--recognising the role of the invisible hand.
Minhas R
Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
[No Abstract] [Full Text] [Related]
6. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
7. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products.
Becker C
Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428
[TBL] [Abstract][Full Text] [Related]
8. Focus on the patent cliff to maximize generic savings.
Cahn L
Manag Care; 2012 Nov; 21(11):28-32. PubMed ID: 23236715
[No Abstract] [Full Text] [Related]
9. [The patent is "engine" in drug development].
Bergström R
Lakartidningen; 2008 Mar 5-11; 105(10):752. PubMed ID: 18422246
[No Abstract] [Full Text] [Related]
10. [The generics reform lowered drug prices].
Lundin D; Jacob J; Engström A
Lakartidningen; 2007 Feb 28-Mar 6; 104(9):680-1. PubMed ID: 17393865
[No Abstract] [Full Text] [Related]
11. Long way down--pharmaceutical companies fear falling off 'patent cliff'.
Sklan A
Pharm Pat Anal; 2012 Jul; 1(3):240. PubMed ID: 24386667
[No Abstract] [Full Text] [Related]
12. Generic drug companies are the winners.
Voth AJ
CMAJ; 1991 Nov; 145(9):1081. PubMed ID: 1751924
[No Abstract] [Full Text] [Related]
13. Generic drugs go to market. Effective, safe and less expensive.
Mayo Clin Health Lett; 2006 Sep; 24(9):4-5. PubMed ID: 17139760
[No Abstract] [Full Text] [Related]
14. Generic HIV drugs will widen US treatment net.
Maxmen A
Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
[No Abstract] [Full Text] [Related]
15. Supreme Court rules against drug patent "evergreening".
Kondro W
CMAJ; 2006 Dec; 175(12):1508-9. PubMed ID: 17146081
[No Abstract] [Full Text] [Related]
16. Reforming Canada's Access to Medicines Regime.
Elliott R
CMAJ; 2007 Jul; 177(3):270-1. PubMed ID: 17664453
[No Abstract] [Full Text] [Related]
17. Handle with care.
Macilwain C
Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170
[No Abstract] [Full Text] [Related]
18. [Free trade agreements make the drugs more expensive].
Jeppsson A
Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499
[No Abstract] [Full Text] [Related]
19. A generic problem.
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
[No Abstract] [Full Text] [Related]
20. Going over the patent cliff.
Schommer JC
Minn Med; 2011 Oct; 94(10):42-3. PubMed ID: 23256283
[No Abstract] [Full Text] [Related]
[Next] [New Search]